02794cam a2200577 i 45000010008000000030006000080050017000140060019000310070007000500080041000570100017000980200034001150200031001490200034001800200031002140200018002450200015002630200026002780350017003040390012003210400052003330420008003850500013003930600013004060820020004190900025004391000042004642450082005062500020005882640086006083000023006943360021007173370023007383380032007615040051007935050720008445060060015645880103016245960007017276500020017346500019017546500029017736500039018026500019018416500019018606500025018798560104019049490018020089260109020267580081021356720287OCoLC20141104152339.0m     o  d        cr |||140530s2015    enk     ob    001 0 eng    a  2014021547  a9781118470961qelectronic bk.  a1118470966qelectronic bk.  a9781118470992qelectronic bk.  a1118470990qelectronic bk.  z9781118470978  z1118470974  z9781118470947 (cloth)  aocn880831304  aexclude  aDLCbengerdacDLCdOCLCOdOCLCAdDG1dN$TdAEU  apcc10aR853.C5510aQV 771.400a615.5/80724223  aInternet AccessbAEU1 aKay, R.q(Richard),d1949- ,eauthor.10aStatistical thinking for non-statisticians in drug regulation /cRichard Kay.  aSecond edition. 1aChichester, West Sussex, UK ;aHoboken, NJ, USA :bJohn Wiley & Sons Inc.,c2015.  a1 online resource.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier  aIncludes bibliographical references and index.0 aBasic ideas in clinical trial design -- Sampling and inferential statistics -- Confidence intervals and p-values -- Tests for simple treatment comparisons -- Adjusting the analysis -- Regression and analysis of covariance -- Intention-to-treat and analysis sets -- Power and sample size -- Statistical significance and clinical importance -- Multiple testing -- Non-parametric and related methods -- Equivalence and non-inferiority -- The analysis of survival data -- Interim analysis and data monitoring committees -- Bayesian statistics -- Adaptive designs -- Observational studies -- Meta-analysis -- Methods for the safety analysis and safety monitoring -- Diagnosis -- The role of statistics and statisticians.  aAccess restricted to authorized users and institutions.  aDescription based on print version record and CIP data provided by publisher; resource not viewed.  a44 0aDrugsxTesting. 0aDrugsxDesign. 0aPharmaceutical industry. 2aClinical Trials as Topicvmethods. 2aDrug Approval. 2aDrug Industry. 2aStatistics as Topic.403University of Alberta Accessuhttp://dx.doi.org/10.1002/9781118470961z(Unlimited Concurrent Users)  hUAINzWILEYOL  aInternet AccesswLCc1i6720287-1001lINTERNETmUAINTERNETrYsYtE-RESOURCEu11/6/2014xE-BOOKzWILEYOL01ahttp://id.loc.gov/authorities/names/n82119999bhttp://viaf.org/viaf/34519737